Skip to content

MaxRets Ventures PLC - Change of Name to MaxRets Ventures plc


Announcement provided by

MaxRets Ventures Plc · MAX

07/02/2023 07:00

MaxRets Ventures PLC - Change of Name to MaxRets Ventures plc
RNS Number : 0887P
MaxRets Ventures PLC
07 February 2023
 

 

 

7 February 2023

Logo, company name Description automatically generated

 

              Greencare Capital PLC

            ("Greencare" or "the Company")

 

          (To be re-named MaxRets Ventures plc)

            Change of Name

Greencare is pleased to announce that, following approval by shareholders at a General Meeting of the Company held on 28 December 2022 to change the Company name, and under the Company's Articles of Association which empower the Directors to amend such name, Greencare is henceforth renamed MaxRets Ventures plc.

The new Company name has been formally registered at Companies House and a Certificate of Incorporation on Change of name issued. The change of name will take effect on the AQUIS Stock Exchange Growth Market (ASX) from 8.00am today, 7 February, 2023 and dealings under the new name will commence immediately thereafter.

The Company's TIDM will also change to MAX. Its ISIN (GB00BJBYK814) remains unchanged.

The Company's website address (which includes the information required by AQSE Rule 4.14) has changed to: www.maxrets.com

Shareholders will be unaffected by the change of name, and existing share certificates remain valid and should be retained.

 

Enquiries:


MaxRets Ventures plc

Dominic White, Chairman

 

c/o Walbrook PR Ltd

 

Cairn Financial Advisers LLP

AQSE Corporate Adviser

Jo Turner / James Lewis

 

+44 (0)20 7213 0880

 

 

  

Walbrook PR Limited

Paul Vann / Nick Rome / Joe Walker

 

+44 (0)20 7933 8780

+44 (0)7768 807631

maxrets@walbrookpr.com

 

Notes:

Change of Investing Strategy

The Board of Greencare firmly believes that, as a result of the current challenging global economic and geopolitical landscape, opportunities now exist to invest in or acquire distressed or out of favour assets which have become undervalued, or, assets which may benefit from consolidation. The Company's underlying investment driver will be technology driven businesses based on their potential future value enhancement and investment returns. The Board has identified four sectors of initial focus, and will likely in future target other technology driven sectors.  These initial sectors include Life Sciences, fintech businesses and assets that use fintech, Impact Investing (Environmental and Renewables) and Retail.

It is the Board's intention, following shareholder approval, to implement a growth incubator and pre-IPO investment philosophy as its investment strategy, whereby it will seek out early stage or undervalued later stage businesses with strong upside potential, with the objective of acquiring, funding, growing and selling-on the investments through the public markets at enhanced valuations.

The board will not restrict the jurisdiction of investments since the application of technology is not constrained by geographic borders, however, the Board would expect that it will consider more investments in Europe.

 

Structure of Investments

Following the passing of the Resolutions, the Company anticipates that investments will be made from the Company's own balance sheet and/or in partnership with other investing entities and will be expected to be in the form of equity and equity-related instruments, including convertible debt instruments, and, debt. The Company may offer its ordinary shares and debt instruments in exchange for shares in investee businesses.

The Company may invest in quoted or listed companies, that are publicly traded, and private companies.  It may acquire investments directly or by way of holdings in intermediate holding or subsidiary entities. The Company may also invest in limited liability partnerships and other forms of legal entity.

The Company may invest in majority or minority positions and will ensure that it has suitable investor protection rights, as determined by the Board.

The Company may, where appropriate and deemed by the Directors to be in the Company's best interests, seek a position on the boards of investee companies to actively monitor and assist the business including helping to scale senior management, inform and refine strategy, drive key performance indicators and provide guidance on future financing. 

The Company intends to realise value through exiting the investments over time and will have no fixed investment period.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAFAKEFNDEAA ]]>

View more ...

MAX announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal